The intracellular signalling pathway signature (the signalome) in PBMCs in the presence of a common TRAPS-associated genetic variant, TNFRSF1A p.(Arg121Gln) (legacy p.R92Q) is distinct from normal PBMCs and from other pathogenic variants (2015)
Attributed to:
Development of a high-content intracellular signalling pathway analysis methodology for drug repurposing
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/1546-0096-13-s1-p19
Publication URI: http://dx.doi.org/10.1186/1546-0096-13-s1-p19
Type: Journal Article/Review
Parent Publication: Pediatric Rheumatology
Issue: S1